Sam A. Eldessouky

Overview 2021 2020

2021

In 2021, Sam A. Eldessouky earned a total compensation of $4.3M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International, a 229% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan	$731,950
Option Awards	$1,187,756
Salary	$620,385
Stock Awards	$1,778,793
Other	$13,340
Total	$4,332,224

Eldessouky received $1.8M in stock awards, accounting for 41% of the total pay in 2021.

Eldessouky also received $732K in non-equity incentive plan, $1.2M in option awards, $620.4K in salary and $13.3K in other compensation.

Rankings

In 2021, Sam A. Eldessouky's compensation ranked 3,060th out of 12,415 executives tracked by ExecPay. In other words, Eldessouky earned more than 75.4% of executives.

Classification	Ranking	Percentile
All	3,060 out of 12,415	75th
Division Manufacturing	1,223 out of 5,505	78th
Major group Chemicals And Allied Products	490 out of 2,375	79th
Industry group Drugs	433 out of 2,096	79th
Industry Pharmaceutical Preparations	295 out of 1,546	81st

Pay ratio

Sam A. Eldessouky's Pay	$4,332,224
Median Employee's Pay	$44,617
Pay Ratio	97 to 1

In 2021, the annual total compensation of Sam A. Eldessouky was $4,332,224.

The annual total compensation of the median employee at Valeant Pharmaceuticals International was $44,617.

The ratio of Sam A. Eldessouky's pay to the pay of median employee was therefore 97 to one.

Source: SEC filing on May 2, 2022.

Overview 2020

Eldessouky's colleagues

We found five more compensation records of executives who worked with Sam A. Eldessouky at Valeant Pharmaceuticals International in 2021.